<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Scilex Holding Company — News on 6ix</title>
<link>https://6ix.com/company/scilex-holding-company</link>
<description>Latest news and press releases for Scilex Holding Company on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 05 May 2026 17:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/scilex-holding-company" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835bdb178dffbe2df117507.webp</url>
<title>Scilex Holding Company</title>
<link>https://6ix.com/company/scilex-holding-company</link>
</image>
<item>
<title>Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-its-subsidiaries-acea-therapeutics-inc-and-acea-pharma-inc-entered-into-a-definitive-agreement-with-phoenix-asia-holdings-limited</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-its-subsidiaries-acea-therapeutics-inc-and-acea-pharma-inc-entered-into-a-definitive-agreement-with-phoenix-asia-holdings-limited</guid>
<pubDate>Tue, 05 May 2026 17:00:00 GMT</pubDate>
<description>PALO ALTO, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its indirect subsidiary, ACEA Therapeutics, Inc, an exempted company incorporated with limited liability in the Cayman Islands (“ACEA</description>
</item>
<item>
<title>Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Re...</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-its-board-of-directors-approved-may-26-2026-as-the-payment-date-of-the-previously-announced-dividend-of-dream-bowl-meme-coin-i-tokens-to-record-holders-of-common-stock-and-other-eligible-equity-securities-as-of-the-re</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-its-board-of-directors-approved-may-26-2026-as-the-payment-date-of-the-previously-announced-dividend-of-dream-bowl-meme-coin-i-tokens-to-record-holders-of-common-stock-and-other-eligible-equity-securities-as-of-the-re</guid>
<pubDate>Mon, 04 May 2026 04:00:00 GMT</pubDate>
<description>Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin</description>
</item>
<item>
<title>Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-its-board-of-directors-approved-a-dividend-of-dream-bowl-i-meme-coin-tokens-to-holders-of-common-stock-and-other-eligible-equity-securities-with-a-record-date-of-april-30-2026</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-its-board-of-directors-approved-a-dividend-of-dream-bowl-i-meme-coin-tokens-to-holders-of-common-stock-and-other-eligible-equity-securities-with-a-record-date-of-april-30-2026</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>PALO ALTO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating</description>
</item>
<item>
<title>Scilex Holding Company Files Federal Securities Fraud Lawsuit Seeking Recovery of Approximately Ninety-Six (96) Million Misappropriated Collateral Shares of Datavault AI, Inc. from Marc Wade, The St. James Bank & Trust Company Ltd., Omega & Corinth Group Ltd., The Bank of New York Mellon Corporation, and Related Parties</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-files-federal-securities-fraud-lawsuit-seeking-recovery-of-approximately-ninety-six-96-million-misappropriated-collateral-shares-of-datavault-ai-inc-from-marc-wade-the-st-james-bank-and-trust-company-ltd-omega-and-corinth-group-ltd-the-bank-of-new-york-mellon-corporation-and-related-parties</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-files-federal-securities-fraud-lawsuit-seeking-recovery-of-approximately-ninety-six-96-million-misappropriated-collateral-shares-of-datavault-ai-inc-from-marc-wade-the-st-james-bank-and-trust-company-ltd-omega-and-corinth-group-ltd-the-bank-of-new-york-mellon-corporation-and-related-parties</guid>
<pubDate>Fri, 13 Mar 2026 15:16:00 GMT</pubDate>
<description>PALO ALTO, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has filed a complaint (the “Complaint”) in the United States District Court for the Central District of California against Marc W</description>
</item>
<item>
<title>Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-20-140000608</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-20-140000608</guid>
<pubDate>Fri, 30 Jan 2026 14:00:00 GMT</pubDate>
<description>PALO ALTO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has made a $20 million strategic investment in Quantum Scan Holdings, Inc. (“Quantum Scan”), a breakthrough medical technology comp</description>
</item>
<item>
<title>Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments</title>
<link>https://6ix.com/company/scilex-holding-company/news/oramed-receives-dollar18-million-payment-from-scilex-holdings-bringing-current-returns-to-dollar118-million-board-approves-dividend-payments</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/oramed-receives-dollar18-million-payment-from-scilex-holdings-bringing-current-returns-to-dollar118-million-board-approves-dividend-payments</guid>
<pubDate>Wed, 07 Jan 2026 13:55:00 GMT</pubDate>
<description>Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) today announced it has received an $18 million payment from Scilex Holdings Inc., representing full satisfaction of obligations under the Option Agreement. This payment brings Oramed's current returns to $118 million on its original $99.5 million Scilex investment, with additional returns expected from the remaining convertible notes, warrants, and royalties.</description>
</item>
<item>
<title>Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-appoints-kasowitz-140000163</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-appoints-kasowitz-140000163</guid>
<pubDate>Fri, 02 Jan 2026 14:00:00 GMT</pubDate>
<description>PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, announced that it has appointed Kasowitz LLP and its founding partner Marc Kasowitz as the Company’s litigation and intellectual property counsel. Kasowitz</description>
</item>
<item>
<title>Scilex Holding Company Announces Closing of Previously Announced Second Tranche Investment in Datavault AI Inc., Completing Its Two-Tranche Equity Financing in Datavault AI Inc.</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-closing-of-previously-announced-second-tranche-investment-in-datavault-ai-inc-completing-its-two-tranche-equity-financing-in-datavault-ai-inc</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-closing-of-previously-announced-second-tranche-investment-in-datavault-ai-inc-completing-its-two-tranche-equity-financing-in-datavault-ai-inc</guid>
<pubDate>Wed, 26 Nov 2025 05:00:00 GMT</pubDate>
<description>Scilex closed the second tranche, purchasing a pre-funded warrant exercisable for 263,914,094 shares of Datavault AI Inc. (Nasdaq: DVLT; “Datavault AI”)</description>
</item>
<item>
<title>Scilex Holding Company Announces Closing of Exercise of Warrants for $20.3 Million Gross Proceeds</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-closing-193700457</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-closing-193700457</guid>
<pubDate>Tue, 25 Nov 2025 19:37:00 GMT</pubDate>
<description>PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, announced today the closing of its previously announced exercise of certain existing warrants to purchase an aggregate of (i) 428,572 shares of common stoc</description>
</item>
<item>
<title>Scilex Holding Company Announces Exercise of Warrants for $20.3 Million Gross Proceeds</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-exercise-110000479</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-exercise-110000479</guid>
<pubDate>Mon, 24 Nov 2025 11:00:00 GMT</pubDate>
<description>PALO ALTO, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, announced today that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of (i) 428,572 share</description>
</item>
<item>
<title>Scilex Holding Company Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin by Datavault AI Inc.</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-regarding-205900855</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-regarding-205900855</guid>
<pubDate>Fri, 21 Nov 2025 20:59:00 GMT</pubDate>
<description>PALO ALTO, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, announced today that, with respect to the voluntary distribution by Datavault AI Inc. (“Datavault AI”) (Nasdaq: DVLT) of Dream Bowl 2026 Meme Coins to reco</description>
</item>
<item>
<title>Oramed Reports Fiscal Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/scilex-holding-company/news/oramed-reports-fiscal-third-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/oramed-reports-fiscal-third-quarter-2025-financial-results</guid>
<pubDate>Mon, 17 Nov 2025 13:55:00 GMT</pubDate>
<description>Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP), a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection, today announced its unaudited financial results for the nine months ended September 30, 2025.</description>
</item>
<item>
<title>Datavault AI Reports 3Q-25 Highlights and Corporate Update</title>
<link>https://6ix.com/company/scilex-holding-company/news/datavault-ai-reports-3q-25-highlights-and-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/datavault-ai-reports-3q-25-highlights-and-corporate-update</guid>
<pubDate>Mon, 17 Nov 2025 13:10:00 GMT</pubDate>
<description>Company Posts Strong Revenue Momentum, Global Licensing Pipeline and Real‑World Asset Tokenization LeadershipQ3-25 Revenue rose 148% YOY to $2.9MDVLT Discusses New Global Business PipelineRaises FY 2025 Revenue Guidance to a low end of $30M, Raises 2026 Guidance to $200MManagement Hosting a Live Webcast at 8:30 a.m. ET; Information Below PHILADELPHIA, Nov. 17, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (Nasdaq: DVLT), a leader in data monetization, credentialing, and digital engagement</description>
</item>
<item>
<title>Datavault AI Inc. Announces a $10M Worldwide Exclusive License Agreement with Scilex Holding Company for Tokenization and Monetization of Real-World Assets (RWA) in Genomic, DNA Data, Diagnostics, Therapeutics, Genetic, and Drug Information</title>
<link>https://6ix.com/company/scilex-holding-company/news/datavault-ai-inc-announces-a-dollar10m-worldwide-exclusive-license-agreement-with-scilex-holding-company-for-tokenization-and-monetization-of-real-world-assets-rwa-in-genomic-dna-data-diagnostics-therapeutics-genetic-and-drug-information-1</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/datavault-ai-inc-announces-a-dollar10m-worldwide-exclusive-license-agreement-with-scilex-holding-company-for-tokenization-and-monetization-of-real-world-assets-rwa-in-genomic-dna-data-diagnostics-therapeutics-genetic-and-drug-information-1</guid>
<pubDate>Tue, 04 Nov 2025 17:52:00 GMT</pubDate>
<description>PHILADELPHIA, Nov. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), a leader in AI-driven blockchain solutions focusing on data monetization, asset tokenization, and secure digital marketplaces, today announced that it has granted a worldwide exclusive license, with the right to sublicense, to Scilex Holding Company (Nasdaq: SCLX), for Datavault AI’s proprietary AI-driven technology. This license is tailored for use within the biotech an</description>
</item>
<item>
<title>Scilex Holding Company Announces Worldwide Exclusive License for Tokenization and Monetization of Real-World Asset (RWA) in Genomic, DNA Data, Diagnosis, Therapeutics Products, Genetic and Drug information from Datavault AI</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-worldwide-110000063</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-worldwide-110000063</guid>
<pubDate>Tue, 04 Nov 2025 11:00:00 GMT</pubDate>
<description>PALO ALTO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has in-licensed a worldwide exclusive license, with right to sublicense, to Datavault AI’s proprietary AI-driven technology for the</description>
</item>
<item>
<title>Scilex Holding Company Announces the Sponsorship of Dream Bowl 2026 and Set a Record Date of November 14, 2025 for Its Shareholders to Receive Dream Bowl 2026 Meme Coin Distributed by DataVault AI</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-the-sponsorship-of-dream-bowl-2026-and-set-a-record-date-of-november-14-2025-for-its-shareholders-to-receive-dream-bowl-2026-meme-coin-distributed-by-datavault-ai</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-the-sponsorship-of-dream-bowl-2026-and-set-a-record-date-of-november-14-2025-for-its-shareholders-to-receive-dream-bowl-2026-meme-coin-distributed-by-datavault-ai</guid>
<pubDate>Mon, 03 Nov 2025 05:00:00 GMT</pubDate>
<description>PALO ALTO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating</description>
</item>
<item>
<title>Datavault AI Converts $13.3 Million in Convertible Debt, Strengthens Balance Sheet</title>
<link>https://6ix.com/company/scilex-holding-company/news/datavault-ai-converts-dollar133-million-in-convertible-debt-strengthens-balance-sheet-1</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/datavault-ai-converts-dollar133-million-in-convertible-debt-strengthens-balance-sheet-1</guid>
<pubDate>Thu, 02 Oct 2025 22:18:00 GMT</pubDate>
<description>BEAVERTON, Ore., Oct. 02, 2025 (GLOBE NEWSWIRE) -- via IBN – Datavault AI Inc. (Nasdaq: DVLT), a pioneer in AI-driven data monetization, today announced the full conversion of certain long term notes with an aggregate original face value of $13.3 million thereby strengthening its balance sheet substantially. Commenting on the debt conversion, Brett Moyer, Datavault AI Chief Financial Officer, said, “Converting these notes is an important strategic milestone and supports the accelerated launch of</description>
</item>
<item>
<title>Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-completion-130000159</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-completion-130000159</guid>
<pubDate>Wed, 01 Oct 2025 13:00:00 GMT</pubDate>
<description>PALO ALTO, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has repurchased 3,130,000 warrants to purchase shares of Scilex common stock having an exercise price of $0.01 per share (“Warrants</description>
</item>
<item>
<title>Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-closing-of-previously-announced-initial-tranche-investment-in-datavault-ai</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-holding-company-announces-closing-of-previously-announced-initial-tranche-investment-in-datavault-ai</guid>
<pubDate>Fri, 26 Sep 2025 04:00:00 GMT</pubDate>
<description>PALO ALTO, Calif. , Sept. 26, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating</description>
</item>
<item>
<title>Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million i...</title>
<link>https://6ix.com/company/scilex-holding-company/news/scilex-announces-closing-of-previously-announced-non-dilutive-value-enhancing-transaction-with-an-institutional-investor-for-the-exchange-of-dollar200-million-of-common-stock-of-semnur-pharmaceuticals-inc-held-by-scilex-holding-company-for-dollar200-million-i</link>
<guid isPermaLink="true">https://6ix.com/company/scilex-holding-company/news/scilex-announces-closing-of-previously-announced-non-dilutive-value-enhancing-transaction-with-an-institutional-investor-for-the-exchange-of-dollar200-million-of-common-stock-of-semnur-pharmaceuticals-inc-held-by-scilex-holding-company-for-dollar200-million-i</guid>
<pubDate>Thu, 25 Sep 2025 04:00:00 GMT</pubDate>
<description>Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of</description>
</item>
</channel>
</rss>